Neurological diseases such as Parkinson’s disease, epilepsy, and schizophrenia affect millions of people around the world. These conditions can seriously impact a person’s movement, thinking, emotions, and daily life.
One of the biggest challenges doctors face is detecting these diseases early. Many neurological disorders develop slowly over many years, and symptoms often appear only after significant damage has already occurred in the brain.
Diagnosing these conditions can also be complicated and expensive. Doctors often rely on brain scans such as PET imaging, blood tests, or even spinal fluid tests to look for signs of disease.
Some of these procedures are uncomfortable, invasive, or costly. Because of these challenges, researchers around the world have been searching for easier and faster ways to detect brain disorders.
Now, a team of researchers in South Korea has developed a promising new method that may allow doctors to detect several major neurological diseases using only a small sample of saliva.
The research was led by Dr. Sung‑Gyu Park from the Korea Institute of Materials Science, working together with Professor Ho Sang Jung from Korea University and medical researchers from The Catholic University of Korea. Their findings were published in the international scientific journal Advanced Materials.
The scientists created a new testing platform that can analyze tiny changes in proteins found in saliva. Proteins are important molecules in the body that carry out many biological functions.
In many neurological diseases, proteins inside the brain begin to change shape and form abnormal structures. These changes can damage brain cells and interfere with normal brain activity.
For example, in Parkinson’s disease, certain proteins can form clumps that harm nerve cells responsible for controlling movement. In other disorders, such as epilepsy or schizophrenia, changes in protein structure may also reflect underlying problems in brain function.
The new technology developed by the Korean research team focuses on detecting these structural changes in proteins. The system uses a technique known as Galvanic Molecular Entrapment combined with a powerful optical method called Surface‑Enhanced Raman Spectroscopy, often shortened to SERS.
Although the name sounds complex, the basic idea is that the technology can detect extremely small chemical signals from molecules.
The system uses special nanostructures made from copper oxide and gold. When proteins from saliva attach to these nanostructures, tiny regions called plasmonic hotspots form. These hotspots dramatically increase the strength of the signals produced by the proteins.
Normally, the signals produced by biological molecules are extremely weak and difficult to measure. However, this new system can amplify those signals more than a billion times. This enormous increase allows researchers to observe subtle changes in protein structure that were previously very difficult to detect.
One of the most important features of the system is its ability to tell the difference between normal proteins and proteins that have formed abnormal structures known as fibrils. These fibrils are often linked to disease processes in the brain.
In the study, the researchers tested saliva samples from patients with several neurological disorders. The team worked with St. Vincent’s Hospital to collect samples from 44 patients who had epilepsy, Parkinson’s disease, or schizophrenia. They also tested saliva samples from 23 healthy individuals who served as a comparison group.
The results were very encouraging. The system was able to distinguish between healthy individuals and patients with neurological disorders with very high accuracy. In most cases, the accuracy exceeded 90 percent and in some cases reached as high as 98 percent.
This level of accuracy is important because the system does not simply measure how much protein is present. Instead, it identifies the structural changes in proteins that are closely related to disease processes. Detecting these changes may provide a much clearer signal of neurological problems than traditional methods that focus only on protein quantity.
Dr. Sung‑Gyu Park explained that the research shows it may soon be possible to evaluate brain disease using only saliva samples. This could remove the need for expensive brain imaging or uncomfortable spinal fluid tests in many situations.
Because the research was published in a highly respected international journal, the scientific community has already recognized the originality and importance of the technology.
Professor Ho Sang Jung also noted that the method could eventually be used outside traditional hospitals. Because saliva testing is simple and non‑invasive, the technology could potentially be developed into portable diagnostic devices that people might use at home or in local clinics.
The researchers are now working on turning the technology into practical diagnostic tools. Their next goal is to develop portable devices based on Raman sensors that can provide rapid testing at the point of care. They also plan to work with medical technology companies to bring the innovation closer to clinical use.
The study represents an exciting step forward in the search for easier ways to detect neurological diseases. Early diagnosis is extremely important for conditions like Parkinson’s disease and epilepsy because treatments often work better when the disease is identified early.
If doctors can detect these conditions sooner, patients may have a better chance of managing symptoms and slowing disease progression.
However, it is important to note that this study was relatively small. Although the results are very promising, larger studies involving more patients will be needed to confirm the accuracy and reliability of the test. Scientists will also need to test whether the technology works equally well across different populations and stages of disease.
Despite these limitations, the research demonstrates a powerful new approach to diagnosing neurological disorders. By focusing on structural changes in proteins rather than simple protein levels, the technology may reveal deeper biological signals related to disease.
In reviewing the study findings, the most important contribution is the development of a non‑invasive, low‑cost diagnostic tool that could greatly simplify neurological testing.
If future research confirms these results, saliva‑based screening could become a practical method for early detection of brain diseases. Such a tool could improve access to diagnosis, reduce healthcare costs, and allow more patients to receive treatment earlier.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more health information, please see recent studies about how wheat gluten might be influencing our brain health, and Olive oil: a daily dose for better brain health..
Copyright © 2026 Knowridge Science Report. All rights reserved.
